Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kovar

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
MMW Fortschritte Der Medizin|April 12, 2013
[Podology]Peter Kovar
MMW Fortschritte Der Medizin|December 15, 2016
[Calluses, corns and others - beware of the self-treatment!]Peter Kovar
Journal of Sports Sciences|March 29, 2016
Sport activities differentiating match-play improvement in elite youth footballers - a 2-year longitudinal studyArne Güllich, Peter Kovar, Sebastian Zart, et al.
Molecular Cancer Therapeutics|April 14, 2005
A-432411, a novel indolinone compound that disrupts spindle pole formation and inhibits human cancer cell growthZehan Chen, Philip J Merta, Nan-Hong Lin, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2011
Scaffold oriented synthesis. Part 3: design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing [2+3] cycloadditionsIrini Akritopoulou-Zanze, Brian D Wakefield, Alan Gasiecki, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2011
Scaffold oriented synthesis. Part 4: design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactionsIrini Akritopoulou-Zanze, Brian D Wakefield, Alan Gasiecki, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2005
Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitorsNan-Horng Lin, Ping Xia, Peter Kovar, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Macrocyclic ureas as potent and selective Chk1 inhibitors: an improved synthesis, kinome profiling, structure-activity relationships, and preliminary pharmacokineticsZhi-Fu Tao, Zehan Chen, Mai-Ha Bui, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2007
Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitorsGaoquan Li, Zhi-Fu Tao, Yunsong Tong, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2007
Synthesis and biological evaluation of 4'-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitorsZhi-Fu Tao, Gaoquan Li, Yunsong Tong, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
MMW Fortschritte Der Medizin|April 12, 2013
[Podology]Peter Kovar
MMW Fortschritte Der Medizin|December 15, 2016
[Calluses, corns and others - beware of the self-treatment!]Peter Kovar
Journal of Sports Sciences|March 29, 2016
Sport activities differentiating match-play improvement in elite youth footballers - a 2-year longitudinal studyArne Güllich, Peter Kovar, Sebastian Zart, et al.
Molecular Cancer Therapeutics|April 14, 2005
A-432411, a novel indolinone compound that disrupts spindle pole formation and inhibits human cancer cell growthZehan Chen, Philip J Merta, Nan-Hong Lin, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2011
Scaffold oriented synthesis. Part 3: design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing [2+3] cycloadditionsIrini Akritopoulou-Zanze, Brian D Wakefield, Alan Gasiecki, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2011
Scaffold oriented synthesis. Part 4: design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactionsIrini Akritopoulou-Zanze, Brian D Wakefield, Alan Gasiecki, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2005
Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitorsNan-Horng Lin, Ping Xia, Peter Kovar, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Macrocyclic ureas as potent and selective Chk1 inhibitors: an improved synthesis, kinome profiling, structure-activity relationships, and preliminary pharmacokineticsZhi-Fu Tao, Zehan Chen, Mai-Ha Bui, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2007
Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitorsGaoquan Li, Zhi-Fu Tao, Yunsong Tong, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2007
Synthesis and biological evaluation of 4'-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitorsZhi-Fu Tao, Gaoquan Li, Yunsong Tong, et al.
Pageof 4